Compare HCA Health Inc (HCA) vs Nvidia Corp (NVDA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Nvidia Corp — how do they compare? HCA Health Inc trades at $443.69 (market cap $95.08B), while Nvidia Corp trades at $233.24 (market cap $5.73T). The key difference: Nvidia Corp is far larger — about 60.3× HCA Health Inc's market cap, and HCA Health Inc pays the higher dividend (0.71%). Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Nvidia Corp for 115 Days on average.
| HCA | NVDA | |
|---|---|---|
Market Cap | $95.08B | $5.73T |
Volume | 998,787 | 81,027,431 |
Sector | Health | Technology |
52-Week High | $545.13 | $239.27 |
52-Week Low | $361.32 | $165.17 |
Typical Hold Time | 76 Days | 115 Days |
Enterprise Value | $145.62B | $5.71T |
Dividend Yield | 0.71% | 0.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $445.01, up 2.96% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.6B in 2025, with net income of $6.78B, and the stock trades at a P/E of 14.73. Analyst consensus is a Buy with a $461.12 price target, though ongoing legal investigations pose a headwind.
The outlook remains positive given solid demand and cost controls, but risks include payer-mix pressure and high debt levels. Upside potential exists if earnings growth continues, but investors should monitor legal developments and interest rate impacts on the leveraged balance sheet.
NVIDIA (NVDA) trades at $230.48, down 3.67% on the day, amid a broader tech sell-off. The stock maintains a bullish technical signal with strong moving averages, though oscillators are neutral and RSI levels suggest potential overbought conditions. Fundamentally, the company reported robust revenue of $130.50B in 2025 with a net income margin of 63.66%, and it has consistently beaten earnings expectations in recent quarters. Recent news highlights AI-driven growth prospects but also notes concerns about market saturation and geopolitical impacts on U.S. equities.
The outlook for NVDA remains positive due to its dominant position in AI chips and accelerating revenue growth, with Wall Street consensus pointing to significant upside from the current price. Key risks include heightened competition, peak AI spending cycles, and macroeconomic volatility. The stock presents a compelling opportunity for growth-oriented investors, but requires monitoring of execution risks and market sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Nvidia Corp
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →
